The cost of Nurtec ODT (rimegepant) can vary significantly depending on insurance coverage, pharmacy, and whether a patient has a valid prescription. Without insurance, a month's supply of Nurtec can cost several hundred dollars.
How Much Does Nurtec Cost Without Insurance?
For individuals without insurance, the retail price for a 30-day supply of Nurtec ODT can range from approximately $800 to over $1,000 [1]. This price reflects the manufacturer's list price and does not include potential pharmacy dispensing fees.
What Savings Options Are Available for Nurtec?
Manufacturer coupons and patient assistance programs can significantly reduce the out-of-pocket cost for eligible individuals. Pfizer, the maker of Nurtec, offers a savings card that can lower the co-pay for commercially insured patients to as little as $10 per prescription [1]. Details on eligibility and program specifics are typically available through the manufacturer's website or at the pharmacy.
How Does Insurance Affect Nurtec's Price?
Insurance coverage for Nurtec varies by plan. Many insurance providers cover Nurtec, but co-pays can differ. Some plans may require prior authorization or have step-therapy requirements, meaning patients may need to try other migraine medications first. The actual cost per month for a patient with insurance depends entirely on their specific health insurance plan benefits.
What is the Typical Dosage for Nurtec?
Nurtec ODT is typically prescribed for the acute treatment of migraine with or without aura. The recommended dose is one 75 mg orally disintegrating tablet as needed [2]. For preventive treatment of episodic migraine, the recommended dose is one 75 mg tablet every other day [2]. A month's supply would therefore depend on the prescribed regimen.
Are There Generic Versions of Nurtec Available?
As of late 2023 and early 2024, generic versions of Nurtec ODT are not yet available. The patent protection for Nurtec is in place, and generic competition has not yet entered the market [3].
When Does Nurtec's Patent Protection Expire?
The patent landscape for pharmaceutical drugs is complex. While specific patent expiry dates can be found on specialized databases, the general availability of generics often hinges on the expiration of key patents and exclusivity periods. Information from DrugPatentWatch.com indicates the patent status for rimegepant, the active ingredient in Nurtec [3].
How Does Nurtec Compare to Other Migraine Treatments?
Nurtec is an oral CGRP receptor antagonist used for both acute migraine treatment and prevention. Other CGRP antagonists include oral medications like Ubrelvy (ubrogepant) and injectable medications such as Aimovig (erenumab), Ajovy (fremanezumab), and Emgality (galcanezumab). The choice between these treatments depends on individual patient needs, effectiveness, tolerability, and cost.
What Are the Side Effects of Nurtec?
Common side effects reported with Nurtec include nausea and upper abdominal pain [2]. Patients are encouraged to report any adverse effects to their healthcare provider.
What Are the Clinical Trial Results for Nurtec?
Clinical trials have demonstrated Nurtec's efficacy in treating acute migraine, with a significant percentage of patients achieving pain freedom and freedom from their most bothersome migraine symptom two hours after taking the medication [2]. Studies also support its use for migraine prevention.
What Is the Mechanism of Action for Nurtec?
Nurtec ODT works by blocking the activity of calcitonin gene-related peptide (CGRP), a molecule involved in the inflammatory process that causes migraine pain [4]. By inhibiting CGRP, Nurtec helps to reduce migraine symptoms.
Sources
1. [Manufacturer Savings Programs and Retail Pricing Information]
2. [Nurtec ODT Prescribing Information]
3. [DrugPatentWatch.com]
4. [Scientific Publications on CGRP Antagonists]